• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchBriacell Therapeutics
    Picture of Briacell Therapeutics logo

    BCTX — Briacell Therapeutics News Story

    $2.900.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $25.27m
    • Enterprise Value
      $1.81m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • BCTX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    BCTX Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:51 AM

    Picture of Briacell Therapeutics logoBriacell Therapeutics
    13/01/2026 14:51
    NASDAQ TRADE HALT  BCTX.O  VOLATILITY TRADING PAUSE AT 09:51 AM
    

    Recent news on Briacell Therapeutics

    See all news
    • Brief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share

      01/06/2026 01:01
    • Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer

      26/05/2026 12:39
    • Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™

      15/05/2026 12:33
    • Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients

      12/05/2026 13:55
    • Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study

      07/05/2026 12:33

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.